These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15781653)

  • 1. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.
    Berezovskaya O; Schimmer AD; Glinskii AB; Pinilla C; Hoffman RM; Reed JC; Glinsky GV
    Cancer Res; 2005 Mar; 65(6):2378-86. PubMed ID: 15781653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
    Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
    J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
    Glinskii AB; Smith BA; Jiang P; Li XM; Yang M; Hoffman RM; Glinsky GV
    Cancer Res; 2003 Jul; 63(14):4239-43. PubMed ID: 12874032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis.
    Mawji IA; Simpson CD; Gronda M; Williams MA; Hurren R; Henderson CJ; Datti A; Wrana JL; Schimmer AD
    Cancer Res; 2007 Sep; 67(17):8307-15. PubMed ID: 17804746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines.
    Laguinge LM; Samara RN; Wang W; El-Deiry WS; Corner G; Augenlicht L; Mishra L; Jessup JM
    Cancer Res; 2008 Feb; 68(3):909-17. PubMed ID: 18245494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphB4 expression and biological significance in prostate cancer.
    Xia G; Kumar SR; Masood R; Zhu S; Reddy R; Krasnoperov V; Quinn DI; Henshall SM; Sutherland RL; Pinski JK; Daneshmand S; Buscarini M; Stein JP; Zhong C; Broek D; Roy-Burman P; Gill PS
    Cancer Res; 2005 Jun; 65(11):4623-32. PubMed ID: 15930280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of ovarian cancer growth by small interfering RNA targeting X-linked inhibitor of apoptosis gene].
    Ma JJ; Chen BL; Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):124-8. PubMed ID: 17442189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
    Seligson DB; Hongo F; Huerta-Yepez S; Mizutani Y; Miki T; Yu H; Horvath S; Chia D; Goodglick L; Bonavida B
    Clin Cancer Res; 2007 Oct; 13(20):6056-63. PubMed ID: 17947468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
    Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
    Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status.
    Ohnishi K; Scuric Z; Schiestl RH; Okamoto N; Takahashi A; Ohnishi T
    Radiat Res; 2006 Sep; 166(3):454-62. PubMed ID: 16972754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.
    Nakano Y; Bilim V; Yuuki K; Muto A; Kato T; Nagaoka A; Tomita Y
    Prostate Cancer Prostatic Dis; 2009; 12(1):34-40. PubMed ID: 18475287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
    Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W
    Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin.
    Rohwer N; Welzel M; Daskalow K; Pfander D; Wiedenmann B; Detjen K; Cramer T
    Cancer Res; 2008 Dec; 68(24):10113-20. PubMed ID: 19074877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anoikis and metastatic potential of cloudman S91 melanoma cells.
    Zhu Z; Sanchez-Sweatman O; Huang X; Wiltrout R; Khokha R; Zhao Q; Gorelik E
    Cancer Res; 2001 Feb; 61(4):1707-16. PubMed ID: 11245487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
    Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
    Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.
    Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K
    Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency].
    Song DX; Chen AM; Guo FJ; Liao H; Xie BZ; Zhu B; Chen C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1197-201. PubMed ID: 18844116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFI16 in human prostate cancer.
    Alimirah F; Chen J; Davis FJ; Choubey D
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.